Effect of anti-inflammatory compounds on actomyosin-adenosinetriphosphate interaction.
D000205:Actomyosin; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000255:Adenosine Triphosphate; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001241:Aspirin; D001555:Benzene Derivatives; D002118:Calcium; D055598:Chemical Phenomena; D011232:Chemical Precipitation; D002621:Chemistry; D002713:Chlorine; D002729:Chloromercuribenzoates; D003720:Densitometry; D004789:Enzyme Activation; D005439:Flufenamic Acid; D006868:Hydrolysis; D007213:Indomethacin; D008027:Light; D008274:Magnesium; D008528:Mefenamic Acid; D009119:Muscle Contraction / Q000187:drug effects; D009124:Muscle Proteins; D009130:Muscle, Smooth / Q000187:drug effects; D009941:Organomercury Compounds; D010636:Phenols; D010648:Phenylacetates; D010653:Phenylbutazone; D011422:Propionates; D011817:Rabbits; D012459:Salicylates; D012542:Scattering, Radiation
D000893:Anti-Inflammatory Agents; D001555:Benzene Derivatives; D002729:Chloromercuribenzoates; D009124:Muscle Proteins; D009941:Organomercury Compounds; D010636:Phenols; D010648:Phenylacetates; D011422:Propionates; D012459:Salicylates; D008528:Mefenamic Acid; D002713:Chlorine; D005439:Flufenamic Acid; D000255:Adenosine Triphosphate; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D010653:Phenylbutazone; D008274:Magnesium; D001241:Aspirin; D002118:Calcium; D007213:Indomethacin